Learn more

NEVADA CANCER INST

Overview
  • Total Patents
    17
About

NEVADA CANCER INST has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are JACKSON LAB, ALTERNATIVE GENE EXPRESSION S L ALGENEX and GENCOM CO.

Patent filings per year

Chart showing NEVADA CANCER INSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ma Yupo 10
#2 Pizzorno Giuseppe 3
#3 Fink Louis M 2
#4 Ward David C 2
#5 Ye Tao 1
#6 Quan Junmin 1
#7 Xu Dan 1
#8 Xu C Wilson 1
#9 Waner Milton 1
#10 Zhang Hui 1

Latest patents

Publication Filing date Title
WO2012071469A2 Histone demethylase inhibitors and uses thereof for treatment o f cancer
WO2010124143A1 Reprogramming of somatic cells with purified proteins
WO2010042800A1 Methods of reprogramming somatic cells and methods of use for such cells
WO2009092042A1 Reprogramming of differentiated progenitor or somatic cells using homologous recombination
WO2008151021A1 Isolation and growth of stem cells from hemangiomas
US2008299077A1 Isolation and growth of stem cells from hemangiomas
US2008182806A1 Use of acetylated or esterificated azacytidine, decitabine, or other nucleoside analogs as oral agents for the treatment of tumors or other dysplastic syndromes sensitive to hypomethylating agents
US2008241110A1 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
CA2631312A1 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)